LDL biochemical modifications: a link between atherosclerosis and aging

References

• Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 2000; 28(12): 1815–26.
   Google Scholar
• Itabe H. Oxidative modification of LDL: its pathological role in atherosclerosis. Clin Rev Allergy Immunol. 2009; 37(1): 4–11.
   Google Scholar
• Apostolov EO, Ray D, Savenka AV, Shah SV, Basnakian AG. Chronic uremia stimulates LDL carbamylation and atherosclerosis. J Am Soc Nephrol. 2010; 21(11): 1852–7.
   Google Scholar
• Apostolov EO, Basnakian AG, Ok E, Shah SV. Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease. J Ren Nutr. 2012; 22(1): 134–8.
   Google Scholar
• Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998; 338(23): 1650–6.
   Google Scholar
• Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, etal. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging. 2012; 5(3 Suppl): S62–72.
   Google Scholar
• Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation. 2004; 110(13): 1868–73.
   Google Scholar
• Najemnik C, Sinzinger H, Kritz H. Endothelial dysfunction, atherosclerosis and diabetes. Acta Med Austriaca. 1999; 26(5): 148–53. [PubMed Abstract].
   Google Scholar
• Paoletti R, Gotto AM, Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation. 2004; 109(23 Suppl 1): III20–6. [PubMed Abstract].
   Google Scholar
• Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004; 109(23 Suppl 1): III27–32. [PubMed Abstract].
   Google Scholar
• Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, etal. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 2001; 103(15): 1955–60.
   Google Scholar
• Carracedo J, Merino A, Briceño C, Soriano S, Buendía P, Calleros L, etal. Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. FASEB J. 2011; 25(4): 1314–22.
   Google Scholar
• Millán J, Pintó X, Muñoz A, Zúñiga M, Rubiés-Prat J, Pallardo LF, etal. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009; 5: 757–65.
   PubMedGoogle Scholar
• Schuh J, Fairclough GF, Haschemeyer RH. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci USA. 1978; 75(7): 3173–7.
   Google Scholar
• Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, etal. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997; 386(6620): 73–7.
   Google Scholar
• Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA. 1979; 76(1): 333–7.
   Google Scholar
• Steinbrecher UP, Fisher M, Witztum JL, Curtiss LK. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res. 1984; 25(10): 1109–16. [PubMed Abstract].
   Google Scholar
• Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev. 2001; 17(6): 436–43.
   Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999; 340(2): 115–26.
   Google Scholar
• Avogaro P, Cazzolato G, Bittolo-Bon G. Some questions concerning a small, more electronegative LDL circulating in human plasma. Atherosclerosis. 1991; 91(1–2): 163–71.
   Google Scholar
• Orekhov AN, Bobryshev YV, Sobenin IA, Melnichenko AA, Chistiakov DA. Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease. Int J Mol Sci. 2014; 15(7): 12807–41.
   Google Scholar
• Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA. 1981; 78(10): 6499–503.
   Google Scholar
• Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 1984; 81(12): 3883–7.
   Google Scholar
• Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991; 88(6): 1785–92.
   Google Scholar
• Itabe H. Oxidized phospholipids as a new landmark in atherosclerosis. Prog Lipid Res. 1998; 37(2–3): 181–207.
   Google Scholar
• Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med. 2002; 8(11): 1211–17.
   Google Scholar
• Kruth HS, Jones NL, Huang W, Zhao B, Ishii I, Chang J, etal. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem. 2005; 280(3): 2352–60.
   Google Scholar
• Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res. 2005; 49(11): 1063–71.
   Google Scholar
• Schober A, Nazari-Jahantigh M, Weber C. MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis. Nat Rev Cardiol. 2015; 12(6): 361–74.
   Google Scholar
• Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA. 1993; 90(14): 6434–8.
   Google Scholar
• Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988; 318(20): 1315–21.
   Google Scholar
• Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, etal. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA. 1994; 91(20): 9441–5.
   Google Scholar
• Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes. 1982; 31(4 Pt 1): 283–91.
   Google Scholar
• Steinbrecher UP, Witztum JL. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes. 1984; 33(2): 130–4.
   Google Scholar
• Klein RL, Laimins M, Lopes-Virella MF. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes. 1995; 44(9): 1093–8.
   Google Scholar
• Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999; 48(5): 937–42.
   Google Scholar
• Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, etal. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999; 100(10): 1134–46.
   Google Scholar
• Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, etal. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000; 404(6779): 787–90.
   Google Scholar
• Sobal G, Menzel J, Sinzinger H. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids. 2000; 63(4): 177–86.
   Google Scholar
• Bucala R, Mitchell R, Arnold K, Innerarity T, Vlassara H, Cerami A. Identification of the major site of apolipoprotein B modification by advanced glycosylation end products blocking uptake by the low density lipoprotein receptor. J Biol Chem. 1995; 270(18): 10828–32.
   Google Scholar
• Bowie A, Owens D, Collins P, Johnson A, Tomkin GH. Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?. Atherosclerosis. 1993; 102(1): 63–7.
   Google Scholar
• Kobayashi K, Watanabe J, Umeda F, Nawata H. Glycation accelerates the oxidation of low density lipoprotein by copper ions. Endocr J. 1995; 42(4): 461–5.
   Google Scholar
• Rabini RA, Fumelli P, Galassi R, Dousset N, Taus M, Ferretti G, etal. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. Metabolism. 1994; 43(12): 1470–4.
   Google Scholar
• Nilsson L, Lundquist P, Kågedal B, Larsson R. Plasma cyanate concentrations in chronic renal failure. Clin Chem. 1996; 42(3): 482–3.
   Google Scholar
• Kraus LM, Kraus AP. Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl. 2001; 78: S102–7.
   Google Scholar
• Park KD, Mun KC, Chang EJ, Park SB, Kim HC. Inhibition of erythropoietin activity by cyanate. Scand J Urol Nephrol. 2004; 38(1): 69–72.
   Google Scholar
• Ramirez R, Carracedo J, Nogueras S, Buendia P, Merino A, Cañadillas S, etal. Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis. J Mol Cell Cardiol. 2009; 47(6): 781–8.
   Google Scholar
• Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ, etal. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation. 2002; 105(24): 2826–9.
   Google Scholar
• Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32(5 Suppl 3): S112–19.
   Google Scholar
• Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension. 2005; 45(6): 1042–9.
   Google Scholar
• Steinbrecher UP, Zhang HF, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med. 1990; 9(2): 155–68.
   Google Scholar
• Jialal I, Fuller CJ. Oxidatively modified LDL and atherosclerosis: an evolving plausible scenario. Crit Rev Food Sci Nutr. 1996; 36(4): 341–55.
   Google Scholar
• Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int. 2005; 68(1): 173–8.
   Google Scholar
• Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, etal. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med. 2007; 13(10): 1176–84.
   Google Scholar
• Guthikonda S, Sinkey C, Barenz T, Haynes WG. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation. 2003; 107(3): 416–21.
   Google Scholar
• Imanishi T, Tsujioka H, Akasaka T. Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Curr Cardiol Rev. 2008; 4(4): 275–86.
   Google Scholar
• Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. Hypertens Res. 2012; 35(11): 1039–47.
   Google Scholar
• Shi Q, Aida K, Vandeberg JL, Wang XL. Passage-dependent changes in baboon endothelial cells – relevance to in vitro aging. DNA Cell Biol. 2004; 23(8): 502–9.
   Google Scholar
• Khaidakov M, Wang X, Mehta JL. Potential involvement of LOX-1 in functional consequences of endothelial senescence. PLoS One. 2011; 6(6): e20964.
   Google Scholar
• Sato I, Morita I, Kaji K, Ikeda M, Nagao M, Murota S. Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cell. Biochem Biophys Res Commun. 1993; 195(2): 1070–6.
   Google Scholar
• Donato AJ, Gano LB, Eskurza I, Silver AE, Gates PE, Jablonski K, etal. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol. 2009; 297(1): H425–32.
   Google Scholar
• Hasegawa Y, Saito T, Ogihara T, Ishigaki Y, Yamada T, Imai J, etal. Blockade of the nuclear factor-κB pathway in the endothelium prevents insulin resistance and prolongs life spans. Circulation. 2012; 125(9): 1122–33.
   Google Scholar
• Zhou X, Perez F, Han K, Jurivich DA. Clonal senescence alters endothelial ICAM-1 function. Mech Ageing Dev. 2006; 127(10): 779–85.
   Google Scholar
• Carracedo J, Buendía P, Merino A, Soriano S, Esquivias E, Martín-Malo A, etal. Cellular senescence determines endothelial cell damage induced by uremia. Exp Gerontol. 2013; 48(8): 766–73.
   Google Scholar
• Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D'Angelo DD, etal. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem. 1992; 267(22): 15274–76.
   Google Scholar
• Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, etal. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 1992; 256(5054): 225–8.
   Google Scholar
• Cooke JP. NO and angiogenesis. Atheroscler Suppl. 2003; 4(4): 53–60.
   Google Scholar
• Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003; 91(3A): 7A–11A.
   Google Scholar
• Tejovathi B, Suchitra MM, Suresh V, Reddy VS, Sachan A, Srinivas Rao PV, etal. Association of lipid peroxidation with endothelial dysfunction in patients with overt hypothyroidism. Exp Clin Endocrinol Diabetes. 2013; 121(5): 306–9.
   Google Scholar
• Haribabu A, Reddy VS, Pallavi C, Sachan A, Pullaiah P, Suresh V, etal. Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Endocrine. 2013; 44(1): 152–7.
   Google Scholar
• Hayashi T, Matsui-Hirai H, Miyazaki-Akita A, Fukatsu A, Funami J, Ding QF, etal. Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc Natl Acad Sci USA. 2006; 103(45): 17018–23.
   Google Scholar
• Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, etal. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell. 2007; 18(11): 4543–52.
   Google Scholar
• Spagnoli LG, Orlandi A, Mauriello A, Santeusanio G, de Angelis C, Lucreziotti R, etal. Aging and atherosclerosis in the rabbit. 1. Distribution, prevalence and morphology of atherosclerotic lesions. Atherosclerosis. 1991; 89(1): 11–24.
   Google Scholar
• McEwen JE, Zimniak P, Mehta JL, Shmookler Reis RJ. Molecular pathology of aging and its implications for senescent coronary atherosclerosis. Curr Opin Cardiol. 2005; 20(5): 399–406.
   Google Scholar
• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408(6809): 239–47.
   Google Scholar
• Zhang X, Qi R, Xian X, Yang F, Blackstein M, Deng X, etal. Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ Res. 2008; 102(2): 250–6.
   Google Scholar
• Csiszar A, Labinskyy N, Zhao X, Hu F, Serpillon S, Huang Z, etal. Vascular superoxide and hydrogen peroxide production and oxidative stress resistance in two closely related rodent species with disparate longevity. Aging Cell. 2007; 6(6): 783–97.
   Google Scholar
• Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biol Chem. 2008; 389(3): 233–41.
   Google Scholar
• Ferguson M, Rebrin I, Forster MJ, Sohal RS. Comparison of metabolic rate and oxidative stress between two different strains of mice with varying response to caloric restriction. Exp Gerontol. 2008; 43(8): 757–63.
   Google Scholar
• Huffman DM, Moellering DR, Grizzle WE, Stockard CR, Johnson MS, Nagy TR. Effect of exercise and calorie restriction on biomarkers of aging in mice. Am J Physiol Regul Integr Comp Physiol. 2008; 294(5): R1618–27.
   Google Scholar
• Meyers MR, Gokce N. Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes. 2007; 14(5): 365–9.
   Google Scholar
• Segura J, Ruilope LM. Obesity, essential hypertension and renin-angiotensin system. Public Health Nutr. 2007; 10(10A): 1151–5.
   Google Scholar
• MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, etal. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990; 335(8692): 765–74.
   Google Scholar
• Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation. 2004; 109(21 Suppl 1): II27–33.
   Google Scholar
• Chang HJ, Chung J, Choi SY, Yoon MH, Hwang GS, Shin JH, etal. Endothelial dysfunction in patients with exaggerated blood pressure response during treadmill test. Clin Cardiol. 2004; 27(7): 421–5.
   Google Scholar
• Higashi Y, Yoshizumi M. [Endothelial function]. Nihon Rinsho. 2003; 61(7): 1138–44.
   Google Scholar
• Järvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, etal. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004; 109(14): 1750–5.
   PubMed Web of Science ®Google Scholar
• Maggi FM, Raselli S, Grigore L, Redaelli L, Fantappiè S, Catapano AL. Lipoprotein remnants and endothelial dysfunction in the postprandial phase. J Clin Endocrinol Metab. 2004; 89(6): 2946–50.
   Google Scholar
• Saini HK, Arneja AS, Dhalla NS. Role of cholesterol in cardiovascular dysfunction. Can J Cardiol. 2004; 20(3): 333–46.
   Google Scholar
• Liu L, Zhao SP, Gao M. [Influence of postprandial hypertriglyceridemia on the endothelial function in elderly patients with coronary heart disease]. Hunan Yi Ke Da Xue Xue Bao. 2002; 27(3): 259–62.
   Google Scholar
• Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004; 43(10): 1731–7.
   Google Scholar
• Poreba R, Skoczyńska A, Derkacz A. [Effect of tobacco smoking on endothelial function in patients with coronary arteriosclerosis]. Pol Arch Med Wewn. 2004; 111(1): 27–36.
   Google Scholar
• Lyon CJ, Law RE, Hsueh WA. Mini review: adiposity, inflammation, and atherogenesis. Endocrinology. 2003; 144(6): 2195–200.
   Google Scholar
• Mitu F, Mitu M. [Physical exercise and vascular endothelium]. Rev Med Chir Soc Med Nat Iasi. 2003; 107(3): 487–93.
   Google Scholar
• Farhat N, Thorin-Trescases N, Voghel G, Villeneuve L, Mamarbachi M, Perrault LP, etal. Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can J Physiol Pharmacol. 2008; 86(11): 761–9.
   Google Scholar
• Niemann B, Chen Y, Teschner M, Li L, Silber RE, Rohrbach S. Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria. J Am Coll Cardiol. 2011; 57(5): 577–85.
   Google Scholar
• Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res. 2009; 50(Suppl): S376–81.
   Google Scholar
• Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull. 2003; 26(1): 1–9.
   Google Scholar
• Hevonoja T, Pentikäinen MO, Hyvönen MT, Kovanen PT, Ala-Korpela M. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Biochim Biophys Acta. 2000; 1488(3): 189–210.
   Google Scholar
• Virmani R, Avolio AP, Mergner WJ, Robinowitz M, Herderick EE, Cornhill JF, etal. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol. 1991; 139(5): 1119–29.
   Google Scholar
• O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol. 2007; 50(1): 1–13.
   Google Scholar